Abstract P158 – Table 1. Difference in change from baseline in metabolic, liver and quality of life parameters for the maraviroc + OBT versus OBT group with bootstrapped 95% confidence intervals.
Measure	Week	Number of participants	Difference between groups in change from baseline	95% confidence interval
BMI, kg/m2	48	45	−0.2	−1.0 to 0.6
	96	45	−0.2	−0.8 to 0.4
Waist circumference, cm	48	43	2.7	−5.1 to 11
	96	42	1.3	−7.3 to 9.9
CD4 cell count, cells/mm3	48	45	70	−35 to 175
	96	44	−47	−135 to 41
Fasting glucose, mmol/L	48	44	−0.1	−0.8 to 0.7
	96	42	0.8	−0.4 to 2.1
HbA1c, mmol/mol	48	45	−2.3	−6.6 to 2.1
	96	45	2.5	−3.0 to 8.0
AST, U/L	48	43	−0.5	−7.2 to 6.1
	96	38	7.0	−3.4 to 17
ALT, U/L	48	44	−5.7	−22 to 10
	96	45	0.5	−19 to 20
Fasting triglycerides, mmol/L	48	44	0.7	−0.1 to 1.4
	96	46	−0.2	−1.0 to 0.6
Fasting LDL, mmol/L	48	40	0	−0.5 to 0.4
	96	41	0	−0.4 to 0.5
Fasting HDL, mmol/L	48	44	0	−0.2 to 0.2
	96	46	0.1	−0.1 to 0.3
Fasting HDL: total cholesterol ratio	48	44	0.3	−0.6 to 1.1
	96	46	−0.3	−1.0 to 0.4
Fasting total cholesterol, mmol/L	48	44	0.1	−0.4 to 0.6
	96	46	0.1	−0.4 to 0.7
Fibroscan median liver stiffness, kPa	48	43	−1.7	−3.8 to 0.4
	96	41	−0.2	−2.0 to 1.6
Fibroscan CAP score, dB/m	48	41	−15	−56 to 25
	96	39	−5.8	−41 to 30
ELF score	48	43	0.3	0 to 0.6
	96	42	0.1	−0.3 to 0.4
Chronic Liver Disease Questionnaire for NAFLD	48	45	−0.3	−1.0 to 0.4
	96	44	−0.5	−1.3 to 0.2